Keefe, Bruyette & Woods Cuts Globe Life (NYSE:GL) Price Target to $190.00

Globe Life (NYSE:GL) had its target price trimmed by Keefe, Bruyette & Woods from $192.00 to $190.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other analysts have also issued reports about the stock. JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Morgan Stanley raised their target price on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. Jefferies Financial Group lifted their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. Finally, Piper Sandler boosted their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $187.40.

Globe Life Price Performance

NYSE GL opened at $173.64 on Friday. Globe Life has a one year low of $127.85 and a one year high of $191.55. The stock has a 50-day moving average of $169.07 and a 200 day moving average of $152.99. The company has a market capitalization of $13.48 billion, a price-to-earnings ratio of 11.53 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the firm posted $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts forecast that Globe Life will post 15.7 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio is presently 8.76%.

Insider Buying and Selling at Globe Life

In related news, CEO Frank M. Svoboda sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Cheryl Alston sold 8,258 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the sale, the director directly owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 90,187 shares of company stock worth $14,299,874 over the last quarter. Company insiders own 2.11% of the company’s stock.

Institutional Investors Weigh In On Globe Life

A number of hedge funds have recently modified their holdings of GL. Compound Planning Inc. raised its holdings in Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after purchasing an additional 82 shares during the period. Root Financial Partners LLC grew its holdings in Globe Life by 23.3% during the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after purchasing an additional 83 shares during the period. Transcend Capital Advisors LLC grew its holdings in Globe Life by 3.9% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after purchasing an additional 84 shares during the period. Natural Investments LLC increased its position in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after buying an additional 87 shares in the last quarter. Finally, Parallel Advisors LLC increased its position in Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after buying an additional 87 shares in the last quarter. Institutional investors own 81.61% of the company’s stock.

Trending Headlines about Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Keefe, Bruyette & Woods trimmed its price target only modestly to $190 from $192 and kept an outperform rating, implying roughly 9% upside from recent levels. Benzinga article
• Positive Sentiment: TD Cowen also reiterated a bullish view, forecasting strong price appreciation for Globe Life (GL). American Banking News article
• Positive Sentiment: Management raised its 2026 net operating EPS guidance to $15.55-$15.95 and lifted share repurchases to $670 million-$700 million, signaling confidence in future earnings and capital returns. Seeking Alpha article
• Neutral Sentiment: Globe Life’s Q2 revenue came in roughly in line with expectations, and underwriting income remained strong, showing the core business is still performing acceptably despite some headwinds. Reuters article
• Negative Sentiment: Q2 earnings of $3.61 per share missed the consensus estimate of $3.67, and several reports pointed to softer sales and rising expenses as reasons for investor concern. MSN article

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.